Home
>
National Drug Code (NDC)
>
Pristiq Extended-Release
Pristiq Extended-Release - 43063-262-30 - (desvenlafaxine succinate)
Drug Information of Pristiq Extended-Release
| Product NDC: | 43063-262 |
| Proprietary Name: | Pristiq Extended-Release |
| Non Proprietary Name: | desvenlafaxine succinate |
| Active Ingredient(s): | 50 mg/1 & nbsp; desvenlafaxine succinate |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, EXTENDED RELEASE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Pristiq Extended-Release
| Product NDC: | 43063-262 |
| Labeler Name: | PD-Rx Pharmaceuticals, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021992 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20080501 |
Package Information of Pristiq Extended-Release
| Package NDC: | 43063-262-30 |
| Package Description: | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (43063-262-30) |
NDC Information of Pristiq Extended-Release
| NDC Code | 43063-262-30 |
| Proprietary Name | Pristiq Extended-Release |
| Package Description | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (43063-262-30) |
| Product NDC | 43063-262 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | desvenlafaxine succinate |
| Dosage Form Name | TABLET, EXTENDED RELEASE |
| Route Name | ORAL |
| Start Marketing Date | 20080501 |
| Marketing Category Name | NDA |
| Labeler Name | PD-Rx Pharmaceuticals, Inc. |
| Substance Name | DESVENLAFAXINE SUCCINATE |
| Strength Number | 50 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Norepinephrine Uptake Inhibitors [MoA],Serotonin and Norepinephrine Reuptake Inhibitor [EPC],Serotonin Uptake Inhibitors [MoA] |
